As of the latest SEC filings, Aktis Oncology, Inc. (AKTS) is held by 85 institutional funds. The largest fund shareholder is VANGUARD HEALTH CARE FUND (VGHAX), holding an estimated $37,943,325.00 in market value, representing 0.10% of its portfolio.
Funds holding Aktis Oncology, Inc. (AKTS)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- AKTS
- CIK:
- 0002035832
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VGHAX
VANGUARD HEALTH CARE FUND
|
MF | Vanguard | 0.10% | $37,943,325.00 | 2,023,644 | Apr 30, 2026 | Jun 26, 2026 |
|
OTCFX
T. Rowe Price Small-Cap Stock Fund, Inc.
|
MF | T. Rowe Price | 0.14% | $10,958,465.83 | 612,547 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $10,838,388.15 | 605,835 | Mar 31, 2026 | May 28, 2026 |
|
ETAHX
Eventide Healthcare & Life Sciences Fund
|
MF | Independent / Boutique | 0.57% | $9,070,230.00 | 507,000 | Mar 31, 2026 | May 29, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.01% | $8,270,690.12 | 462,308 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.14% | $7,729,014.15 | 383,955 | Feb 28, 2026 | Apr 24, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.05% | $5,970,698.05 | 333,745 | Mar 31, 2026 | May 28, 2026 |
|
TRSSX
T. Rowe Price Institutional Small-Cap Stock Fund
|
MF | T. Rowe Price | 0.13% | $5,738,217.50 | 320,750 | Mar 31, 2026 | May 28, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.08% | $5,364,705.39 | 266,503 | Feb 27, 2026 | Apr 24, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.01% | $3,802,256.25 | 202,787 | Apr 30, 2026 | Jun 26, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $3,751,085.75 | 209,675 | Mar 31, 2026 | May 28, 2026 |
|
PASVX
T. Rowe Price Small-Cap Value Fund, Inc.
|
MF | T. Rowe Price | 0.04% | $3,655,767.83 | 204,347 | Mar 31, 2026 | May 28, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 0.03% | $3,521,163.47 | 196,823 | Mar 31, 2026 | May 28, 2026 |
|
MSGAX
Meridian Small Cap Growth Fund
|
MF | Independent / Boutique | 0.80% | $1,888,647.30 | 105,570 | Mar 31, 2026 | Jun 1, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.01% | $1,528,825.73 | 85,457 | Mar 31, 2026 | May 28, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.01% | $1,435,171.58 | 80,222 | Mar 31, 2026 | May 28, 2026 |
|
BMEZ
BlackRock Health Sciences Term Trust
|
CEF | BlackRock / iShares | 0.10% | $1,047,692.07 | 58,563 | Mar 31, 2026 | May 28, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.01% | $846,112.50 | 45,126 | Apr 30, 2026 | Jun 25, 2026 |
|
-
Master Small Cap Index Series
|
ETF | Independent / Boutique | 0.01% | $587,400.26 | 32,834 | Mar 31, 2026 | May 28, 2026 |
|
TRHBX
Nuveen Small Cap Blend Index Fund
|
MF | TIAA / Nuveen | 0.01% | $458,775.00 | 24,468 | Apr 30, 2026 | Jun 24, 2026 |
|
BME
BlackRock Health Sciences Trust
|
CEF | BlackRock / iShares | 0.08% | $415,566.81 | 23,229 | Mar 31, 2026 | May 28, 2026 |
|
TRSGX
T. Rowe Price Spectrum Moderate Growth Allocation Fund
|
MF | T. Rowe Price | 0.01% | $378,725.82 | 18,814 | Feb 28, 2026 | Apr 27, 2026 |
|
-
EQ/2000 Managed Volatility Portfolio
|
ETF | Independent / Boutique | 0.01% | $363,471.13 | 20,317 | Mar 31, 2026 | May 26, 2026 |
|
-
Adara Smaller Companies Fund
|
ETF | Independent / Boutique | 0.05% | $343,941.18 | 17,086 | Feb 28, 2026 | Apr 28, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $296,414.25 | 14,725 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)